Payá Eduardo, Marín Francisco, González Josefa, Gimeno Juan Ramón, Feliu Eloísa, Romero Antonio, Ruiz-Espejo Francisco, Roldán Vanessa, Climent Vicente, de la Morena Gonzalo, Valdés Mariano
Department of Cardiology, Hospital General Universitario, Alicante, Spain.
J Card Fail. 2008 Jun;14(5):414-9. doi: 10.1016/j.cardfail.2008.02.006. Epub 2008 May 27.
Hypertrophic cardiomyopathy (HCM) shows increased myocardial collagen and disarray. Late gadolinium enhancement in cardiovascular magnetic resonance (CMR) is observed in regions of increased myocardial collagen. The extent of late gadolinium enhancement has been associated with higher prevalence of risk factors of sudden death. The aim of the present study was to describe the clinical characteristics and the presence of risk factors for sudden death in a series of patients from 2 referral centers for HCM in relation to late gadolinium enhancement in CMR.
A total of 120 patients (47 +/- 16 years) were included. All patients fulfilled conventional criteria for HCM. A complete history and clinical examination were performed. Risk factors for sudden death were evaluated. A blinded CMR was performed with late gadolinium enhancement in the left ventricular short-axis orientation. NT pro B-type natriuretic protein (BNP) and C-reactive protein were determined in serum samples. A total of 83 patients (69%) showed late gadolinium enhancement. These patients had higher maximal left ventricular wall thickness (22 +/- 5 versus 17 +/- 3 mm, P < .001), showed more frequently obstruction (42% versus 16%, P = .006), nonsustained ventricular tachycardia (38% versus 8%, P = .001), worse exercise capacity (8 +/- 4 versus 10 +/- 4 METs, P = .003) and increased levels of NT BNP (656 [300-1948] versus 290 [122-948] pg/mL, P = .020). On multivariate analysis, maximal left ventricular wall thickness (P < .001) and nonsustained ventricular tachycardia (P = .011) remained associated with gadolinium-enhanced imaging. Number of risk factors for sudden death was associated with late gadolinium enhancement (OR 2.18, 95%CI 1.45-3.20, P < .001).
Late gadolinium enhancement in CMR is a common finding in HCM. Increased maximal left ventricular wall thickness and nonsustained ventricular tachycardia are associated with late gadolinium enhancement. Associations with risk factors for sudden death and functional status are observed.
肥厚型心肌病(HCM)表现为心肌胶原蛋白增加和排列紊乱。心血管磁共振成像(CMR)中的延迟钆增强在心肌胶原蛋白增加的区域可见。延迟钆增强的范围与猝死危险因素的较高患病率相关。本研究的目的是描述来自两个HCM转诊中心的一系列患者的临床特征以及与CMR延迟钆增强相关的猝死危险因素的存在情况。
共纳入120例患者(47±16岁)。所有患者均符合HCM的传统标准。进行了完整的病史和临床检查。评估了猝死的危险因素。采用左心室短轴方向的延迟钆增强进行了盲法CMR检查。测定血清样本中的NT-pro B型利钠肽(BNP)和C反应蛋白。共有83例患者(69%)出现延迟钆增强。这些患者的最大左心室壁厚度更高(22±5对17±3mm,P<.001),更频繁出现梗阻(42%对16%,P=.006)、非持续性室性心动过速(38%对8%,P=.001),运动能力更差(8±4对10±4代谢当量,P=.003),且NT BNP水平升高(656[300-1948]对290[122-948]pg/mL,P=.020)。多因素分析显示,最大左心室壁厚度(P<.001)和非持续性室性心动过速(P=.011)仍与钆增强成像相关。猝死危险因素的数量与延迟钆增强相关(比值比2.18,95%可信区间1.45-3.20,P<.001)。
CMR中的延迟钆增强在HCM中是常见表现。最大左心室壁厚度增加和非持续性室性心动过速与延迟钆增强相关。观察到与猝死危险因素和功能状态的关联。